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to 19 (average 12.6 years). All the patients had their salivary glands 
involved, in most cases gl. parotis (alone or together with gl. submax- 
iuaris). All the patients, except two, had a fever (average 2.4 days). 
The urine amykse was elevated in 63.6% cases. All the patients 
recovered. Most of them had leukopenia or normocytosis with a 
moderate increase in ESR. 
Conclusions: During the mumps outbreak 30.7% of the vacci- 
nated students fell d. The form of the disease both for the vaccinated 
and nonvaccinated patients was easy. 
Epidemiology of opportunistic infections in 
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[p14541 Endogenous S. aureus Recolonizes the Nares 
of HIV-infected Patients after Mupirocin 
Treatment 
E Perdreau-Remington, N. Huynh, J.N. Martin, M. Webb, 
M. Kartahja, O.G. Pasi, B.L. Lee, H.E Chambers, M.G. Tauber, 
J.L. Gerberding. Univeaity of Calfornia, Snn Francisco, U S A  
Background Nasal carriage of S. sums has been associated with an 
increased risk of infection. Temporary eradication can be achieved 
with intranasal mupirocin. 
Objective: To determine the source of recurrent S. aureus colo- 
nization following mupirocin treatment in HIV+ patients. 
Methods: Subjects were enrolled in a randomized, triple-blind 
clinical trial of mupirocin treatment (2% ointmentld for 5 days) of 
HIV-infected patients with persistant S. aureuc nasal carriage. Nares 
were cultured at baseline and 1, 2, 6, and 10 weeks post-treatment. 
Recurrent isolates (after initial eradication) were compared with 
pre-treatment isolates. Mupirocin sensitivity and PFGE of restriction 
hgments obtained after SmaI and KspI dgestion were performed 
on all isolates. 
Results: Nare cultures were negative at one or more follow-up 
visit in 34 of38 (85.3%) patients who received mupirocin. Recurrent 
colonization was not associated with the development of mupirocin 
resistance. Post-treatment cultures were positive in 14.7% at week 
1; 37.5% at week 2; 58.1% at week 6, and 73.5% at week 10. In 
20123 recurrent cases, the pre- and post-treatment isolates repre- 
sented the same done. In 5 of these, the follow-up DNA profiles 
differed from the origmal done in 2-3 bands, changes attributable 
to genetic events aEecting a smgle restriction site. Three patients ac- 
quired a new clone. Two patients did not respond to treatment and 
remained colonised with their initial clone. 
Conclusions: In this HIV-infected population, recurrence of S. 
aurm after mupirocin treatment was mainly due to recolonisation 
with the initial strain and was not associated with drug resistance. 
Long term eradication was compromised by the patients' own flora. 
Single genetic events affecting the fingerprints were fiequent even 
during this relatively short period of observation. 
-1 Bacteremia and Fungemia in HIV-Infected 
R. Manfkedi ', A. Nanetti ', M. Ferri *, 0. Coronado I ,  
A. Mastroianni I ,  E Chiodo l .  'Department ofExperimentul and 
Clinicul Medicine, Division of Infectious Diseuses, University of Bologna, 
Bologna, Italy, 'Department ofExperimenta1 and Clinical Medicine, 
Division ofMkrobioloD, University of Bologna, Bologna, Italy 
Objective: To assess the spectrum of bacterial and fungal pathogens 
responsible for disseminated infection in HIV-infected patients @). 
Hospitalized Patients 
Methods: During a 6-year period, 4682 blood cultures were per- 
formed to identlfy bacteria, fungi and mycobacteria in HIV-mfected 
hospitalized p, sdering h m  suspected heminaced infection: 851 
(18.2%) tested positive, leading to the isolation of 778 bacteria and 
fungi in 709 diEerent p (mycobacteria were excluded h m  t h ~ ~  
study). 
Results: Among the 748 identified bacteria, gram-positive mi- 
croorganisms largely predominated (580 isolates: 77.5%), while 
gram-negative accounted for the 18.6% of isolates, and anaerobes 
for the 3.9%. In particular, catalase-positive cocci represented the 
great majority of gram-positive bacteria (513 strains): Staph. aunw 
in 42 cases, S. epidermis in 246, other coagulase-negative staphylo- 
cocci in 131, Corynebacterium sp. in 39, Micmcocw sp. in 38, Baril- 
lus sp. in 10, and Rhodocoms equi in 7 p), while catalase-negative 
cocci were isolated in 67 cases (Enterocorcus faecalis in 29, E .  faedum 
in 5, Sh. pneumoniae in 9, and Sheptococw sp. in 24 p). Among 
gram-negative agents, enterobacteriaceae were isolated in 59 cases 
(goup D salmonellae in 30, group B/C salmonellae in 6, Escherichia 
coli in 12, Senatia marcesm in 8, Enterobacter sp. in 2, and Mebsiella 
pneumoniae in 1 p), oxidase-negative bacjlli in 46 cases (Xantomom 
maltophilia in 40, Xantomonas sp. in 1, and Acinetobader sp. in 5 p), 
and oxidase-positive bacilli in the remaining 34 cases (Pseudomom 
aentpinosa in 16, Pseudomom sp. in 7, Alculigenes sp. in 5, Flavibac- 
tm'um sp. in 3, and other bacteria in 3 p). Anaerobic bacteria were 
cultured in 29 cases (Ropionibaderium acnes in 26, Bacferoides sp. in 2, 
and Fusobderium sp. in the remaining p). Finally, fungemia (30 cases 
on the whole) was caused by Cryptococnrs neoformuns in 25 p, Candida 
albicans in 4, and C .  norvegensis in the remaining p. Discussion: The 
episodes of bacteremia and fungemia affecting p with HIV &ease 
present a broad etiological spectrum. Gram-positive bacteria prove to 
be the most kquent agents, with coagulase-negative staphylococci, 
enterococci, and Rhodo- equi as emerging pathogens. Among 
gram-negative organism, an elevated fiequency of Salmonelk and 
Pseudomom sp. is observed, while an increasing incidence of Xun- 
tomonas and Senafia sp. is recorded. Opportunistic yeasts (mostly C. 
neoformans) are responsible of all cases of fungemia. An estimate of 
the etiological spectrum of disseminated infection complicating ad- 
vanced HIV disease may represent an useful reference in order to 
plan empiric antimicrobial treatment of presumed bacterial or fungal 
sepsis in HIV-infected p. 
lp14561 Xanthomonas maltophilia Infection in the 
Setting of HIV Disease 
R. M d d ' ,  A. Nanetti', M. Fern', E Chiodo'. 'Dept. of 
Expm'menfal and Cliniral Medicine, Division ofIt$ectious Diseuses, 
University of Bologna, Bologna, Italy, 'Dept. of Microbiolon, University 
of Bologna, Bologna, Ituly 
Objective: To evaluate the fiequency and sigdcance of Xan- 
thornonus maltopilia (Xm) complications in HIV-infected patients (p). 
Methods: A retrospective review of clinical records of nearly 2000 
HIV-infected p followed since 1991 was performed to identlfy Xm 
infections, and to evaluate their occurrence and outcome according 
to several epidemiological, dimcal, and laboratory variables. 
Results: As a whole, 54 episodes of Xm infection occurred in 52 p 
out of 2000 (-2.6%): 38 males and 14 females, aged 21-54 years (25 
ex-i.v. drug users, 15 heterosexuals and 12 homosexuals). Pathogens 
were isolated finom blood cultures in most cases (44 episodes), and 
h m  BAL or respiratory secretions (5), urine (2), pharyngeal swab 
(2), and lymph no& biopsy (1). X m  represented the fourth most 
common etiological agent of bacteremia in our series, behind Stuphy- 
lococw aunus, S. epidermidis and coagulase-negdtive staphylococci (44 
cases of 781: 5.6%). Fourteen episodes of 54 occurred as polymi- 
crobial infections, with staphylococci, Pseudomom aeruginosa and 
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salmonellae as the most common associated pathogens. Only 13 
of 54 episodes of X m  lnfection (24.1%) were community-acquired, 
whereas most cases were detected after the third day of hospitaha- 
tion; in one p a concomitant colonization of an indwelling central 
i.v. catheter was seen. X m  infections were related to a deep im- 
munodeficienq, characterized by a mean CD4 cell count of 67.1 
3~ 23.9/pl, (with 37 episodes of 54 associated with a CD4 count 
<50/pL). Leukopenia-neutropenia (WBC t1500/pL and/or neu- 
trophils clOOO/pL) were present in 24 out of 54 episodes (44.4%), 
and 34 p of 52 (65.4%) had a previous diagnosis of A I D S .  On the 
other hand, no sigdcant Merence was found when strahfjmg p 
according to age, sex, or type of risk for HIV infection. X m  isolates 
showed high resistance levels against a large spectrum of antibiotics: 
280 of strains tested resistant against ampicfin, mezlocillin, aztre- 
onam, imipenem, first- and second-generation cephalosporins and 
aminoglycosides, while a sensitivity 260% was shown by piperacan, 
ticarcillin-clavulanate, ceftazidirne, quinolones and cotrimoxazole. 
An appropriate i.v. chemotherapy was carried out in all p with 
X m  infection, mostly with bd-generation cephalosporins (36 p), 
piperacdlin (10). or quinolones (6), alone or associated with amino- 
glycosides or cotrimoxazole, obtaining c h c a l  and microbiological 
cure 111 51 cases of 54 (94.4%) after 7.8 f 3.4 days, while in the 
remaining 3 episodes of X m  sepsis, occurring in p with a CD4 
count of 5-30/pL and a WBC count of 80G1550/pL, this in- 
fection contributed to death. Two p suffered from a relapse of X m  
infection, occurred after 1-2 months. Discussion: X m  is an emerging 
nosocomial pathogen in immunocompromised p. but very limited 
informations are available about its clinical role in the setting of HIV 
infection, with only a few cases of bacteremia and localized infec- 
tion reported until now In our series, X m  complications presented 
remarkable fiequency and severity, not previously recognized to the 
same extent. X m  infection seemed to show a broad clinical spec- 
trum, an mcreasing risk accordmg to the progression of HIV disease, 
and a fiequent association with other HIV-related complications. 
When some adjunctive risk factors are present (far advanced im- 
munodeficiency, leukopenia-neutropenia, hospitalization and instru- 
mentation), X m  should be regarded as a potentially life-threatening 
pathogen, because of its tendency to cause disseminated disease and 
its fkequent multiple antibiotic resistance. 
I PI457 I Bordetella bronchiseptica: A Recently 
Recognized Opportunistic Agent in AIDS 
A. Mastroianni, 0. Coronado, A. Nanetti, R. Manfiedi, E Chiodo. 
L-tihrto Mafattie Infettiue UniuersitA di Bologna, Italy 
Objective: To review four cases of Bordetelfa bronchiseptica respiratory 
tract Sections that occurred in patients with AIDS seen at our 
hospital in the past three years, with a focus on clinical characteristics, 
and pattern of antimicrobial susceptibdity. 
Methods: Patients with B. bronchiseptica dection at the 
Sant'Oaola University Hospital were identified through a retro- 
spective review of microbiology records fivm 1994 through 1996; 
clinical data were obtained by subsequent chart review. 
Results: For the 3-year study period, 4 isolates from respiratory 
tract specimens were identified. All four patients were males, and had 
underlying HIV disease; three patients were homosexuals, and one 
was intravenous drug user. Fever (temperature, >38.5"C), weight 
loss, dyspnea, and cough were common symptoms. One patient pre- 
sented with a prolonged p m d  cough resembling pertussis. Chest 
radiography revealed normal findmgs for only one patient, parenchy- 
mal changes for two patients, and increased bronchovascular mark- 
ings in one patient. The risk of exposure to B. bronchiseptica b m  dog 
contact has been hypotesized for one patient. Susceptibility testing 
was performed for isolates from a l l  the four patients. All were resis- 
tant to aarfreonam, and susceptible to imipenem, meziocillin, pipmacillin, 
and tirarcillin/clauulanate. Three of four isolates tested were susceptible 
to cipr@oxm'n, gentamycin, amikan'n, and tobramycin. Two isolates had 
high level resistance to ceftaridime, and one isolate had intermediate 
susceptibihty to ceftzidime. One isolate displayed low-level resistance 
to amikm'n, gentamycin, and tobramycin, and high level resistance to 
azfreonam, ceftazidime, and ciproJoxm'n. Ditferent antimicrobial regi- 
mens were prescribed in all cases. None of these four patients died, 
but many had severe disease. 
Conclusion: B. bronchiseptica is noted primarily as a veteri- 
nary pathogen, and it is generally considered an organism of low 
pathogenicity in clinical settings, yet in recent years a number of 
sporadic reports of human disease caused by this bacterium have 
been described, especially as opportunistic respiratory complications 
among patients with AIDS. Although previously anecdotal reports 
have described successful treatment with ciprofloxacin, the o p d  
choice and duration of antibiotic therapy are not known. 
I PI458 [ Penicillin-Resistant Pneumococci in AIDS 
A. Mastroianni, 0. Coronado, A. Nanetii, R. Manfiedi, E Cluodo. 
Lcfituto Mafattie Infettiue, Uniuersitd. di Bologna, Italy 
Objective: To describe the emergence of infections caused by Strep- 
tocoaus pneumoniae with decreased susceptibility to penicfin and to 
verlfy the presence of multiresistant S. pneumoniae in patients with 
HIV disease actending one AIDS chic.  
Methods: Prompted by several reports of severe drug-resistant 
S. pneumoniae infections, we initiated surveillance for AIDS patients 
with serious drug-resistant pneumococci disease in 1989. 
We have pedormed a retrospective review of the records of aIl 
hospitalized patients from whom pneumococcal isolates had been 
recovered between 1989 and 1995. Initial testing for penicilhn re- 
sistance was pedormed using the 1 p g  o x a c b  dlsks. Susceptibil- 
ity testing against selected agents were performed with use of the 
agar ctlution method, in accordance with the methods of the NC- 
CLS. The following antibiotics were tested: ampicillin, qhalotin,  din- 
damycin, erythromycin, piperadin, tefrqcline, and cotrimoxazole. The 
criteria for determining the h4lCs of penicillin G were as follows: 
t0.06 pg/ml, susceptible; 0.12 to 1 pg/ml, intermediately resistant; 
>2  pg/ml, highly resistant. Pneumococci were defined as multiply 
resistant to antibiotics ifthey were resistant to three or more different 
antibimimbd agents. 
Results: Fourty-five consecutive clinical isolates of S. pneumo- 
niae were collected during the study period. Twenty-eight strains 
were isolated from sputum, ten h m  blood, five from BAL, and 
two b m  ear. The majority of strains were susceptible to ampicillin, 
piperm'llin, and cephalofin. Of the 45 isolates, 37% were shown to 
have an intermediate susceptibility to penicillin G; however none of 
the isolates were classified as lughly resistant. In addltion, 49% of the 
strains were resistant to cotrimoxazole, 15% were resistant to tetracy- 
cline, 5% were resistant to erythromycin, and 5% were resistant to clin- 
damycin. The percentages of pneumococd intermediately resistant to 
clindamycin, and to erythromycin were 20% and 7%, respectively. It was 
notable that 60% of the intermediately resistant strains to penicillin 
showed a decreased susceptibility to multiple antimicrobial agents. 
Conclusion: This study suggests that relative resistance to penicillin 
and resistance to multiple antimicrobial drugs is emerging as a priority 
for clinicians caring patients with AIDS in our hospital. Awareness of 
the increasing fkquency of S. pneumoniae resistance to penicillin, cotri- 
moxazole, tetrqcline, erythromycin and clindamycin, is important in the 
choice ofan appropriate antimicrobial treatment in immunocompro- 
mised patients. We stress that the control ofinfections related to pneu- 
mococci with multiple resistance to antibiotics, and more rational use 
ofantibiotics may limit the spread of these strains. 
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[ PI459 1 Is the Epidemiology of Kaposi's Sarcoma in 
HIV Changing? 
M.M. Calvo, A. Maiello, G. Dassio, G. Meneghm, M. Sciandra, 
A. Sinicco. Dept. Med. Sug. Sciences, Sect. Igect. Diz., Univ. Turin, 
Jtaly 
Objective: to assess if Kaposi's sarcoma (KS) epidemiology among 
HIV+ patients is changing. 
Methods: from 01/87 to 11/96, every case of KS dmgnosed and 
confirmed by biopsy was analyzed regard sex, age, CDC stage at 
diagnosis, CD4+ cell count. Fmally, we evaluated epidemiological 
trend of KS dunng our observation period. 
Results: overall we saw 1380 HIV+ patients. Out of them, 66 
(4.8%) had KS (males: 64, females: 2); median age: 38 yr (R.: 
21-65). At hagnosis, the median CD4+ cell count was 66.5//~L 
(R.: 1-508). In 46/66 (69.7%) cases KS was the first AIDS defining 
event (21 group I1 CDC, 7 group 111, 18 group N C 2  CDC). In 
these patients the median CD4+ cell count was lOO/@L (R. 1-508); 
in the remaining patients it was 54/pL (R.: 11-179). 
n +Wh C M  ; =** N 100 50 
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In our study population, t Student's test showed no sigmflcant 
difference at onset of KS regard to CD4+ mean count, incidence 
and mean age tivm 87 through 96. 
Conclusions: the epidemiology of KS seems to be unchanged. 
[-I HIV Unrelated Malignancies Among HIV 
M.M. Cdvo, I. Cassetta, G. Dassio, A. Maiello, M. Sciandra, 
A. Sinicco. Dept. Med. Sug. Sciences, Sect. Igect. Dis, Unit? Turin, 
lnfeeted Patients 
Italy 
Objective: to perform a retrospective study about prevalence and 
type of HIV unrelated malignancies among HIV+ patients. 
Methods: we reviewed all cases of HIV unrelated malignan- 
cies diagnosed and histologically c o n f i e d  from 1/87 until 11/96 
among HIV infected patients admitted to our Institute. 
Results: omrall we saw 1380 HIV+ patients. Out of them we 
diagnosed 21 (1.5%) cases of malignant tumor other than AIDS 
d e f i g  malignancies [18 M, 3 F; median age: 42 years (R: 22-71); 
median CD4+ cell count: 307/pL (37-660); risk 10 IDUs, 6 het- 
erosexual, 4 homosexual men, 1 blood recipient; 12 group I1 CDC, 
4 group 111 CDC, 3 group IVC2 CDC, 2 group IVCl CDC]. The 
tumor types are shown in the table. 
~ 
Type of cancer n (%) (%)unongHHIV+ 
Hodgkm's dvevc 7 33.3 0.51 
Lung cancer 4 19 0.29 
Gvtric cancer 2 9.5 0.14 
Colon-Ecal cancer 2 9.5 0.14 
Prostxc cancer 2 9.5 0.14 
A d  skin cancer 1 4.8 0.07 
Multiplcrnyelom 1 4.8 0.07 
ALL 1 4.0 0.07 
HCC 1 4.8 0.07 
Eleven patientr (52.4%) died from tumor. 
Conclusion: Our data seem to demonstrate that HIV unrelated 
dgnancies  are m among HIV infected patients like.1~ because of 
younger age. 
(p14611 Cardiovascular Abnormalities in HIV Infected 
K. Ngu Blackett, D.E. Nzeobontane, C. Kuaban. EM.B.S. 
University .f Yhounde I ,  Cameroon 
Objectives: To study cardiovascdar abnormalities in HIV infection 
and their relationship to the immunological status of patients. 
Methods: In a cross sectional descriptive study of 75 patients re- 
ferred to CHU Yaounde for HIV testing (HIV 1, including sero 
type 0, and HIV 2; using ELISA and Western Blot), 54 patients were 
seropositive of which 30 had AIDS according to the WHO Bangui 
criteria and 21 were seronegative. Afeer dinical appraisal, ECG and 
car&ac ultrasound examinations were performed, and cardiowcular 
autonomic function (CAF) assessed. Lymphocyte immunopheno- 
typing (CD3; CD4; CD8;) was performed by flow cytometry on 
all HIV+ve patients. Data were analysed using Students T test; Chi 
squared with Yates correction and ANOVA. 
Resultx Sius tachywdia, arrhythnxas and non spec& T mve 
changes were more fkquent in AIDS patients. There was a highly 
sigmfcant difference in CAF between HIV(+) and HIV(-) patients 
(p < 0.001). Ofthe AIDS patients only one had normal W, where 
as no HIV(-) patient had autonomic dysfunction. Pericardial e f i -  
sion did not appear to influence CAE Echocardiography showed 
dilated cardiomyopathy (DCM) in 7 patients with AIDS; 1 HIV(+) 
patient, but none in the HIV(-) group. The mean CD4 count was 
142 f 67 in patients with DCM and 231 f 191 in those without 
DCM. Pencardial disease was present in 15 patients with AIDS, 7 
HN(+) and 5 HW(-) patients. 
Conclusion: DCM, and abnormal cardiovascukr autonomic 
function were all sq&icantly higher in AIDS patients than HIV(+) 
non AIDS and HN(-) patients, and were associated with lower 
CD4 counts. 
Patients in Yaounde Cameroon 
1 PI462 I Incidence and Prevalence of Rare 
HIV-Associated Diseases (RD) in the Swiss HIV 
Cohott Study (SHCS) between 1989 and 1994 
B. Burckhardt, J. Drewe, N. Gyr, M. Battegay for the SHCS. Dept. 
Oflnternal Medicine, Univ. Hosp. Basel, Switzerland 
Objective: To determine trends in incidence and prevalence of 
RD among HIV-positive individuals living in Switzerland. RD were 
defmded as diseases with an annual incidence of less than 1% of all 
registered diseases. 
Methods: 6887 HN-positive individuals were followed between 
January 1989 and December 1994 in the SHCS. A total of 14,997 
new diseases were reported in the same time interval. Analysis of 
incidence and prevalence of RD. 
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Results: Most RD increased in eequency and all RD taken to- 
gether significantly increased from 7.9% to 18.6% between 1989 and 
1994, mady  due to CMV-retinitis (0.82% to 2.22%). other CMV 
diseases (0.86% to 1.42%) and thxombocytopenia (0.60% to 1.34%) 
and a sharp increase of a large spectrum of HIV-related illnesses. No 
sigmficant change in prevalence was observed (Fig). 
Conclusions: A sipficant change in incidence of RD was no- 
ticed. The prevalence however did not change sigmfkantly. Doctors 
caring for HIV-infected patients will be increasingly confknted with 
RD. 
ten) to 4 (2 clusters) patients. 7/12 clusters included patients from 
Merent centers. RFLP showed 11 (15%) clustered isolates divided 
in 5 clusters of 2 (4 clusters) and 3 patients. Chart review of pa- 
tients with clustered isolates revealed strong suspicion of carry-over 
contamination in one case. 
Conclusion: PFGE detected a higher number of clusters than 
RFLP. This could be related to the mobihty of the insertion element 
IS1245 detected by RE€! Person-to-person transmission was un- 
likely to have occurred among the 4 SHCS centers. The clustering 
of isolates points to common environnmental sources of MAC for 
Swiss  AIDS patients. 
I PI463 I Molecular Typing of Pneumocystis cariniif.sp. 
hominis by Single Strand Conformation 
Polymorphism 
PM. Hauser ', D.S. Blanc I ,  J. Bille I ,  A. Telenti ', P. Francioli 
'Centre Hospitalier Universitaire Eudois, Lausanne, Switzerland, 
'Institut de Mimobiologie Midicale, Beme, Switzerland 
To study Pneumocystis rarinii fsp. hominis epidemiology, we have de- 
veloped a molecular typing method. It consists in the amplifica- 
tion by PCR of four variable regions of the genome from bron- 
cho-alveolar lavages of patients, followed by the detection of their 
variation by the single-strand conformation polymorphism tech- 
nique (SSCP). Two broncho-alveolar lavages collected at an interval 
of 2.5 weeks fiom the same patient gave the Same SSCP pattern for 
each of the four regions suggesting that these regions of the genome 
are stable. Two or three different SSCP patterns with two bands, 
each band corresponding to one of the two single strands of the 
PCR product, were identifled for each region. Sequencing revealed 
that the sequence morphs responsible for the Merent SSCP pat- 
terns present a single to several bps polymorphisms. Some patients 
were probably infected by a single strain since they showed a single 
sequence morph of each region. The combinations of the four se- 
quence morphs of these patients were all different so that different 
strains were distinguished. Other samples generated three or four 
SSCP bands which were shown to correspond to the presence of 
two sequence morphs of the region, possibly due to co-infections. 
Some patients could have been co-mfected since they showed two 
sequence morphs of at least one of the regions. Co-infections d 
complicate interpretation of typing data for epidemiological studies 
The results suggest a great diversity of I! rarinii f.sp. hominis strains. 
Thus, the method should be useful for epidemiological studies. 
Molecular Epidemiology of HIV-Associated 
Tuberculosis in Switzerland 
J.-Ph. Jacques, G. Pwer ,  P. Sudre, T. Bodmer, H. Furrer, J. Von 
Overbeck, S .  Bassetti, J.-C. PBarem, R. Weber for the Swiss HW 
Cohort Study (SHCS). H C U G E ,  CH-1211 Ceneve 14, Switzerland 
Objectives: To determine the relative conmbution of reactivation 
of tuberculosis (TB) infection and recent transmission to the inci- 
dence of TB among HIV infected persons in Switzerland and to 
iden* clusters of patients diseased with identical strains. 
Methods: Patients with confirmed TB and isolates avdable who 
were enrolled in the Swiss H N  Cohort Study (SHCS) were eligible 
for this study. Isolates were genetically characterized by restriction 
fragment length polymorphism (RFLP). Detailed c h c a l  and epi- 
demiological information was obtained fiom the SHCS data base 
and retrospective chart review. 
Results: Out of 7999 patients participating in the SHCS, 262 
(3.2%) were diagnosed with pulmonary or extra-pulmonary TB of 
whlch 139 (49%) could be analyzed by RFLP. Of these, 38 (27%) 
had TB isolates with similar R E P  patterns, grouped in 13 clusters 
(i.e. 13 Werent speclfic RFLP patterns). Cluster size varied between 
2 patients (9 dusters) and 10 (1 cluster); 8 clusters implicated patients 
from more than one city. Within a cluster, the time span between the 
first and the last TB diagnoses averaged 27 months [2-62 months]. 
Out of 14 patients (9%) with more than one TB episode, 13 reacti- 
vated the initial st ra in  (identical RFLP after imtial cure), and 1 was a 
re-mfection. 
Conclusions: Recent and ongoing TB transmission occurs among 
HIV lnfected patients in Switzerland and involves approximately one 
quarter of cases reported. Further analysis is in progress to identlfy risk 
factors for cluster cases and recent transmission ofTB 
I PI464 I Relatedness of M. avium Isolates Causing 
lnvasive Infections in Swiss AIDS Patients 
Hj. Furrer', T. Bodmer2, R. Troller', L. Matter2, R. Malinverni' 
for the Swiss HIV Cohort Study (SHCS). 'Med. Policlinic, Univ. 
Beme, Berne, Switzerland, 21nst. Med. Microbial., Univ. Berne, Berne, 
Switzerland 
Objectives: To assess the relatedness of invasive M. avium (MAC) 
isolates in AIDS patients of the Swiss HIV Cohort Study (SHCS) by 
using two distinct genetic tools. 
Methods: A random sample of MAC isolates &om all patients 
with invasive infections enrolled in the SHCS was chosen for the 
period of 1991 to 1995 from four SHCS centers. Analysis ofisolates 
was done by pulsed-field gel electrophoresis (PFGE, Asel restriction) 
and restriction hgment-length polymorphism (RFLP, h u l l  restric- 
tion, probe: IS1245). C h c a l  and epidemiological information was 
obtained by retrospective chart review. 
Results: First isolates fiom 72 patients (31% of all MAC infec- 
tions) were analyzed by PFGE and RFLP PFGE revealed 30 (42%) 
clustered isolates belonging to 12 clusten ranging fiom 2 (8 clus- 
I P1466 I Epidemiological Surveillance of 
Mycobactenurn avium Complex (MAC) 
Cross-Contamination in an AIDS Care Unit by 
Pulsed Field Gel Electrophoresis 
P. Potiquet, C. Roure, C. Neyret, B. Druel, A. Boibieux, 
S .  Tigaud. Hdpital Croix-Rousse, Lyon, France 
Objectives: cross-contamination of AIDS patients by M .  tuberculosis, 
especially in a nosocomial context, is a well known and frequently 
reported occurrence. On the contrary, cross-contamination by MAC 
is a rare occurrence. Netherless, we think that the risk is not Zero; 
because of accumulation, in the same place, of patients with severe 
immunodepression. So, the aim of this study is to build in our Iabora- 
tory the tool of control and diagnostic of such contamination, if any. 
Patients, Strains and Methods: 0.25 strains isolated in our 
laboratory, from 24 patients. 17 from pulmonary sample, 8 from 
Blood-culture. 19 inpatients of our hospital, 5 from outside hospi- 
tals, included as control. Identification performed by hybridation of 
Gene-Probe@ avium-intracellulare complex specific probe. 
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PFGE: All conditions slightly modified h m  Slutsky and all UCM, 
july 94). The restriction enzyme is AsnI, recognising AT’TAAT, 
giving 12 to 20 bands, h m  10 to 800 Kb. Electrophoresis on 1% 
agarose in TBE uses Gene Navigator h m  Pharmacia. 
Results: all the strains but one have been typable,. For one strain, 
it has not been possible to get restriction, after several tentatives. 
The similarity of the strains has been studied using Taxotron soft- 
wax, UF’GMA method, but all the patterns were obviously Wer- 
ent, exept in one case. In one case, the patterns were very close, with 
similarity percent of 90%. 
These strains have been isolated from two unrelated patients, ex- 
cept the fact that they were hospitalised in the same unit the same 
week. 
Conclusion: it is not possible to proof, in this case, the 
cross-contamination, but such observation lead us to dread MAC 
n o s o c o d  contarnination. 
Disseminated MAC Disease in the Swiss HIV 
Cohort Study: Increasing Incidence, 
Unchanged Prognosis 
N. Low’, D. Muger’, M. Egger’.’ for the Swiss HIV Cohort 
Study (SHCS). ‘King’s College School ofMedicine, London, UK, 
2Departments of Social and Beuentiue Medicine, University o f h e ,  
Switzerland, Departments o j  Social and Reuentive Medicine, University 
oflausanne, Switzerland 
Objectives: To examine time trends for occurrence of, and survival 
with, disseminated Mymbacfehm avium complex &ease (DMAC) in 
the large Swiss HIV Cohort Study, 1987-1995. 
Methods: Participants who were kee of DMAC at registration 
were stratified by calendar period (1987-89, 1990-92, 1993-95) 
in which the f is t  recorded CD4 cell count was 0-49, 50-99, or 
100-199 x 106/L. Kaph-Meier lifetable methods and Cox regres- 
sion models were used for statistical analysis. 
Results. The analysis was based on 6052 participants and 202 
incident episodes of DMAC. In individuals with CD4 counts of 
0-49 the cumulative incidence at two years was 9.8% (95% CI 
4.4-15.2%) in 1987-89, 21.5% (15.3%-27.8%) in 1990-92 and 
29.8% (20.8-38.8%) in 1993-95 compared to approximately 3% in 
all time periods for those with CD4 counts above 100. However, 
after controlling for CD4 cell count there was no sigdcant effect 
of calendar period. Median survival following diagnosis of DMAC 
was 7.9 months with no improvement over time. 
Conclusions: The increase in the incidence of DMAC is ex- 
plained by the more profound level of immunosuppression of in- 
dividuals enrolled in recent years. SuMval following diagnosis of 
DMAC has not improved. 
I P1468 I Opportunistic Infections of CNS in HIV/AIDS 
Patients 
S. Parkhomenko ’ , B. Osetrov ’, G. Gurkalo ’, N. Chaika ’. ’Ci ty  
AIDS Centre, Sr. Petersburg, Russia, ‘Medical Arademyfor Postgraduate 
Education, St. Petusburg, Russia, 3Pasteur Institute, St. Petersburg, 
‘ 
Russia 
Objectives: To study the aetiology and clinical signs of secondary 
infections of central nervous system (CNS) in HIV-positive persons. 
Methods: Since 1987 134 cases of HIV mfections and AIDS 
were diagnosed in St. Petersburg (males - 87, females - 47; age dis- 
tribution. t 2 0  years - 2%, 21-30 yean - 36%, 31-40 years - 48%, 
41-50 years - 13% and >50 years - 1%). All patients were under 
observation by neurologist and other physicians at City AIDS Cen- 
ue. Every year according to clinical indications most patients (85%) 
were treated periodically at City Hospital for Infectious Diseases or 
Republican Chical Infectious Hospital. 
Results: Mild immunodeficiency was diagnosed in most casa 
(2A, 2B and 3A stages of infection in 89% of patients; 3B and 3C 
stages - in 11% of patients). Neurological signs and symptom were 
found in 54% of patients. The bequent and most serious CNS lesion 
was chronic meningoencephalitis that was ckagnosed in 13 patients: 
Cryptorom neoformans - 5 ,  Cytomegalovirus - 3 (plus CMV retinitis 
in 2 patients), Herpes simplex virus - 2, HIV - 2 (subacute HIV 
encephalitis and H N  dementia), C. neoformanr+Cundida albiram - 
1. Ten of 13 patients died; the average duration of life in subacute 
cryptococcosis was 6 months h e r  diagnosis of mycotic infection. 
Conclusions: Infections of CNS are among the leading causes of 
death in HIVIAIDS cases. Therefore all patients should be observed 
regularly by neurologist for early treatment of CNS complications. 
[p1469] Intestinal Microsporidiosis in HIV-Infected 
Patients with Diarrhea in Spain 
C. del AguJa I ,  V Soriano ’, R. Navajas I ,  M. Subirats ’, S. Fenoy I ,  
E. Valencia ’, M. Baquero 3 ,  N. Pieniazek 4. University San Pablo, 
Spain, ’Inst. de Salud Carlos UI, S. Minobiologia, Spain, 3S.  
Enfmedades Infecciosas, Spain, 4 C D C ,  Atlanta, USA 
Objecfives: To study the prevalence rates of microsporidiosis and other 
enteric pathogens in HIV-infected patients with darrhea in Spain. 
Identification of microsporidia species implicated in the process. 
Methods: A prospective study of 43 AIDS patients with diarrhea 
was carried out. The presence of parasites, viruses and bacteria was 
investigated in stool samples. Microsporidia identification was made 
by Webex’s chromotrupe-based stain, IIF and PCR tests. IIF was per- 
formed by using rabbit anti-Enrephalitozoon intestinalis, anti-E. hellem 
or anti-E. nrniculi sera. PCR was performed on purified DNA h m  
specmens using E. bieneusi-, E. intestinal&, E. hellem- and E. cuni- 
nrli-specific primers. 
Results: Enteric pathogens were identified in 44.1% of patients 
studied. Crptosporidium sp. was the most common pathogcn found 
(16.2%), followed by microsporidia (13.9%). In all six patients with 
microsporidiosis, Enterorytozoon biubeusi was demonstrated by PCR. 
Five of them presented chronic diarrhea and malabsomon was shown 
in four. Severely depressed CD4 lymphocyte counts in peripheral 
blood were common to all of them. 
Conclusions: Microsporidiosis is a common cause of chronic 
diarrhea in HIV-infected patients in Spain also. The PCR tech- 
nique using specific primers is an adequate and reliable method for 
identifing microsporidia spores in stool samples h m  patients with 
intestinal microsporidiosis. 
-1 Risk of Toxoplasmic Encephalitis in AIDS 
0. Djurkovif-Djakwt ’, B. Bobit ’, D. Vukovit I ,  Dj. Jevtovit ’. 
‘Iwtitute for Medical Research, Belgrade, Yugoslavia, ’Institute for 
Idecfious and Fopical &eases, University of Belgrade, Belgrade, 
Yugoslavia 
Objectives: To determine the kquency rate of taxoplasmic en- 
cephalitis (TE) in AIDS patients in Yugoslavia, and to analyse the 
contribution of age, sex, HIV transmission risk factors, CD4+ T cell 
counts and systemic PCP prophylaxis as risk factors for the develop- 
ment of TE. 
Patients and Methods: Of the 399 patients diagnosed with 
AIDS h m  1991 to 1995 in Yugoslavia, 288 patients (72%), in- 
cluding all with neurological abnormalities, were serologically tested 
for specific Toroplazma gondii IgG by the Sabin-Feldman test and/or 
Patients in Yugoslavia 
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ELISA, and IgM antibodies by the ISAgA. TE was w o s e d  on the 
basis of both neuroradiographical (CT scan and/or h4RI) findmgs 
and clinical and neuroradiographical improvement following specific 
antitoxoplasmosis treatment. 
Results: T gondii-specific IgG antibody was detected in 127 of 
the 288 patients tested serologically (44.1%). TE occurred in 31 pa- 
tients (7.8%), sigmficantly more often (x2  = 34.423, p < 0.005) 
among the seropositive (29/127, 22.8%) than among those seroneg- 
ative (2/161, 1.24%). By survival analysis, the cumulative incidence 
of TE in the seropositive patients was 32.7% for 60 months (30% 
for 24 months). While not associated with sex (p = 0.495), age 
(p = 0.157), or any HIV transmission risk factor (i.v. drug use, p 
= 0.112; blood transfusion, p = 0.758; homosexual contacts, p = 
0.219; other, p = 0.858), the risk for the development of TE in- 
creased with the decrease in the CD4+ T cell count (RR = 0.276, 
95% CI = 0.19814.673, p = 0.0013), and was reduced in patients 
on systemic PCP prophylaxis (RR = 0.222, 95% CI = 0.0684.642, 
p = 0.006). 
Conclusions: The risk of developing TE was the highest in T 
gondii seropositive patients with low CD4+ T cell counts who did 
not receive toxoplasmosis-effective prohylaxis, shown to be benefi- 
cial. Without prophylaxis, a risk existed even at 200-500 x 106A 
CD4+ cells. Negative toxoplasmosis serology was shown to be a 
strong negative predictor. 
I] Oropharyngeal Yeast Carriage in HIV-Infected 
G. Simon, V. Virkonyi, A. SAl, A. Horvith. National Institutefor 
Dermato- Knereology, Budapest, Hungary 
In order to determine the c h i d  sigmficance of oropharyngeal can- 
didosis (OPC) in patients infected with HIV-1, a retrospective study 
was done in 1700 samples from HIV-infected persons at our HIV 
Outpatients Clinic. Yeast carriage was determined by means of oral 
swabs. Yeasts were cultured quantitatively on Sabourauds and on 
yeast extract containing agar plates. Colonies were idennfied bio- 
chemically to species level. 
Yeasts were grown in 74% of HIV-positive patients, with a h- 
quency of 92% in patients with dinical signs, and of 61% without 
episode(s) of OPC, respectively. Yeast colonization was remarkably 
higher in patients with lower CD4+ lymphocyte counts. The dom- 
inant species was Candida dbkans (86%). Mixed infection was de- 
tected in only one patient with OPC. 
Our data do not correlate with those of recent literature on the 
higher incidence of mixed and non-olbicans infections, due to the 
ketoconazole and nystatin therapy in the previous years. On the 
other side, our patient population is reduced only on asymptomatic 
HIV-infected persons. For this reason, the recently administered flu- 
conazole does not play important role in the increased prevalence of 
mixed and non-albicans infections. 
Patients 
I P1472 1 Mucocutaneous Problems in HIV-Positive 
N. Schaub I ,  €? Itin ', S .  Courvoisier 
Th. Rufli 
(SHCS) '. 'Department ofDermatology, University o f h e / ,  Switzerland, 
'Department of Internal Medicine, University of Batel, Switzerland 
Objectives: To determine the incidence of mucocutaneous prob- 
l em in HIV-dected patients, the impact of risk groups and chang- 
ing trends withm the last two years. 
Methods: Within 59 months we included in our study 482 pa- 
tients with proven HIV infection. 
Patients: A Prospective Cohort Study 
N. Gyr ', A. Tietz ', 
M. Battegay ' for the Swiss HIV Cohort Study 
Results: Our cohort included 136 women (28.2%) and 346 men. 
145 patients (30.1%) belonged to the risk group of homosexuality, 
31 were bisexual (6.5%), 97 heterosexual (20.1%) and 185 were i.v. 
drug users (38.4%). The age at the first reactive HIV-test ranged 
between 15 and 68 years (mean 30). HIV-related skin problems such 
as candida-stomatitis developed in 201 (41.7%) patients and Kaposi's 
sarcoma in 31 men (9% ofmen). The most common HIV associated 
dermatological problems were dry skin (232, 48.1%), tinea (210, 
43.6%), seborrheic dermatitis (170, 35.3%). verrucae vulgares (139, 
28.8%), folliculitis (122, 25.3%) and herpes simplex (72, 14.9%). 60 
patients had condyloma acuminata (12.4%), 53 mollusca contagiosa 
(11%) and 23 showed bacterial infections (4.8%). 78 patients (16.2%) 
had a reactive syphilis serology. 
Conclusions: Our data demonstrate that the most common skin 
problems in HIV+ patients are dectious diseases. Homosexuals had 
a higher incidence of Candida-stomatitis and seborrheic dermati- 
tis. Seborrheic dermatitis whch may be related to Malasseziafir+r 
develops early in the disease process but has no impact on the prog- 
nosis. In contrast mollusca contagiosa and Kaposi's sarcoma indicate 
markedly reduced CD4 cell count. Our demographics show that the 
incidence of mucocutaneous problems have not changed dramati- 
cally within the last two years. 
1 PI473 I Wasting Syndrome and AIDS: Prevalence, Risk 
Factor and Survival in the Swiss HIV Cohort 
Study 
Ph. Sudre, C. Pichard, V. Gabriel, B. Hirschel for the Swiss HIV 
Cohort Study (SHCS). HCUGE, CH-1211 Geneve 14, Switzerland 
Objectives: To determine the prevalence, risk factors and survival 
associated with wasting syndrome as the initial AIDS-defining con- 
dition in the Swiss HIV Cohort Study (SHCS). 
Methods: Patients enrolled in the SHCS and diagnosed with 
AIDS were eligible for this study. Those with wasting as the initial 
AIDS defining condition were compared to those diagnosed with 
another condition at the time of AIDS using univariate and multi- 
variate logistic regression. Survival was assessed with Kaplan-Meier 
Results.: Out of 3124 patients eligible, 105 (3.4%) entered AIDS 
with wasting as the initial AIDS defining dagnosis. A large propor- 
tion, however, (42%) had at least one addtional concurrent AIDS 
defining condition and were excluded &om this analysis. Patients 
with wasting (61) were similar to those with another AIDS defining 
illness with respect to gender (2.1% vs 1.6% for male and female), 
age, region of origin and year of AIDS diagnosis. IV drug users, 
however, were 3.5 times more likely to be dngnosed with wasting 
than patients infected through homosexual contact. This increased 
risk was even larger when confoundmg variables were adjusted for 
(Odds ratio: 4.2; 95% CI: 3.4-4.9). Median survival time after AIDS 
was 13 months for wasting patients and 17 months for the others (p 
log rank = 0.19) and this diflerence was mainly due to early wasting 
syndrome associated death after AIDS. 
Conclusions: Wasting syndrome as an AIDS defining illness is 
rare in the SHCS. Drug abusers have an increased risk of being 
diagnosed with wasting at the time of AIDS. Patterns of wast- 
ing-associated mortality need to be explored further. 
analysis. 
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